A carregar...
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
Background: Immunotherapy has drastically changed the outlook for melanoma patients over the past decade. Specifically, the dual blockade of immune checkpoints using ipilimumab and nivolumab has shown unprecedented response rates and survival outcomes. This immense achievement, though, is at the cos...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464656/ https://ncbi.nlm.nih.gov/pubmed/32824780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082329 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|